A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin
← catalyst calendarSponsored by Cinclus Pharma Holding AB (industry) · CINPHA.ST — their whole pipeline →.
Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Na · None · Treatment
Enrollment
12actual
Sites
1
Country
Sweden
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-11-11 | actual | When the study began enrolling |
| Primary completion | 2025-12-22 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-12-22 | actual | The whole study's end, after follow-up |
| First posted | 2025-12-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-27 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Drug Interaction
- GERD (Gastroesophageal Reflux Disease)
- Safety, and Tolerability
Intervention
- Drug: Drug Drug Interaction
Primary outcomes
what the primary-completion date above is the date OFCharacterization of the PK of amoxicillin following a repeated dose before and after repeated administration of linaprazan glurate (AUC)
measured Day 1 and Day 8
Characterization of the PK of amoxicillin following a repeated dose before and after repeated administration of linaprazan glurate (Cmax)
measured Day 1 and Day 8
Characterization of the PK of amoxicillin following a repeated dose before and after repeated administration of linaprazan glurate (Tmax)
measured Day 1 and Day 8
Characterization of the PK of amoxicillin following a repeated dose before and after repeated administration of linaprazan glurate (CL/F)
measured Day 1 and Day 8
Permalink · CINPHA.ST's whole pipeline · Catalyst calendar · Every registered study · What changed